Corcept Therapeutics (CORT) Interest Coverage Ratio (QoQ) (2010 - 2017)
Powered by 
Analysis
Corcept Therapeutics (CORT) Interest Coverage Ratio (QoQ) (2010 - 2017) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Corcept Therapeutics | 11.76 Bn | 11.46 Bn | 252.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2017 | 519.75% |
| Mar 31, 2017 | 72.51% |
| Dec 31, 2016 | 93.60% |
| Sep 30, 2016 | 122.12% |
| Jun 30, 2016 | 193.11% |
| Mar 31, 2016 | -59.39% |
| Dec 31, 2015 | 1,544.36% |
| Sep 30, 2015 | 109.58% |
| Jun 30, 2015 | 69.94% |
| Mar 31, 2015 | -33.92% |
| Dec 31, 2014 | 33.44% |
| Sep 30, 2014 | 16.62% |
| Jun 30, 2014 | 43.55% |
| Mar 31, 2014 | -30.96% |
| Dec 31, 2013 | -9.75% |
| Sep 30, 2013 | 13.70% |
| Jun 30, 2013 | -0.93% |
| Mar 31, 2013 | -9.94% |
| Dec 31, 2012 | 29.26% |
| Sep 30, 2012 | 99.19% |